Risultati per: Guida pratica all’uso farmaci ipoglicemizzanti inclusi nella Nota 100 AIFA

Sequestro medicinali e sostanze dopanti per oltre 2 mln di euro

Tachipirina resta medicinale più venduto nonostante lieve calo

Compie 25 anni la Giornata nazionale di Raccolta del Farmaco

Stroke, Volume 56, Issue Suppl_1, Page A100-A100, February 1, 2025. Background:High adherence to the Mediterranean Diet (MeDi) was associated with better cognitive performance and decreased memory decline among Hispanic or Latino adults.Objective:Investigate if higher adherence to the MeDi improves white matter (WM) integrity among Hispanic/Latino adults and if this effect is mediated by cardiovascular health (CVH).Methods:We included 2,774 participants from the Study of Latinos-Investigation of Neurocognitive Aging-MRI Ancillary Study. Participants completed 24-hour dietary recalls at baseline (2008-2011) which were used to calculate a MeDi score (MeDiS, range 0-9). Brain MRI and diffusion tensor images were collected between 2018 and 2022 on a 3T MRI scanner using a standardized protocol. WM integrity was ascertained using WM hyperintensity (WMH) volume and fractional anisotropy (FA). WMH volumes were residualized for total cranial volume and Ln-transformed prior to analysis. The association of MRI outcomes with MeDiS and its components was investigated using weighted linear regression analysis with complex survey design adjusting for age, sex, sociodemographic characteristics. Cardiovascular health was assessed using the Life’s Simple 7 (LS7, range 0-14) score. The mediating effect of LS7 on the primary outcome was reported as Average Causal Mediation Effects (ACME) and Average Direct Effects (ADE). Statistical significance was set at p

Si è riunito il 29 gennaio per la prima seduta del 2025

Esperti, ‘da depressione ad Alzheimer si studiano nuovi usi”

Rallenta la ricerca sui farmaci in Italia che con le sperimentazioni cliniche – passate nel 2023 a 611 dalle 663 dell’anno prima (-7,8%) – muove ogni anno 700-800 milioni di…

Nistico’, sistema italiano tiene ma -7,8% trial,1 su 3 oncologico

Fujifilm Diosynth Biotechnologies costruirà i nuovi impianti nel sito danese di Hillerød in grado di produrre una maxi coltura di cellule per le terapie

Richiesti esami e controlli. ‘Pazienti vigilino sui sintomi’

Multilingue, chiarirà dubbi e timori assunzione medicinali

Rinnovati anche i fondi per gli screening dell’epatite C